רווח תפעולי לפני פחת: opgen.com (OPGN)

OpGen, Inc. (OPGN) faces a liquidity shortage and the threat of delisting, yet GURU.Markets quotes shape this chart, where the actual size of operating profit via records a new level. The company is developing an express diagnostic system for antibiotic resistance for hospitals, while operational processes are strictly limited by FDA medical regulations regarding the disposal of biomaterials.

This indicator is calculated as the difference between revenue and operating expenses, excluding depreciation, which allows for the determination of actual cash flow from core operations and the identification of trend reversal points in profitability. For OpGen, Inc. (OPGN), which is actively investing in AI platforms and DNA tests, current cash operating profit serves as a metric for the efficiency of R&D commercialization and the sustainability of the business model.